333 research outputs found
Coupling Between Thermal Oscillations in the Surface of a Micro-Cylinder and Vortex Shedding
his article studies the coupling between prescribed thermal oscillations in the surface of a micro-cylinder and vortex shedding. We deal with the unsteady, laminar, compressible flow regime where the aerodynamics forces have a periodic behavior. It is shown that appropriate spatial and time-dependent temperature oscillations on the surface of the micro-cylinder create a resonance that controls the amplitude and frequency of both lift and drag coefficients. In practice, what we study is a mechanism to modulate the amplitude and frequency of mechanical loads of aerodynamics origin in a micro-structure by using surface temperature fluctuations as the control parameter
Hybrid model of the plasma accelerator with open walls and closed electron drift
The original approach to use Hall-type plasma accelerators with closed electron drift and open walls for
production converging towards axis accelerating ion beam describes here. The two-dimensional theoretical hybrid
model was created. The performed computer modeling showed that in high-current mode the potential drop forms at
the axis. This effect can be used for self consistent accelerating the ions moving toward the system center and then
along the axis in both directions.ΠΠΏΠΈΡΠ°Π½ΠΎ ΠΎΡΠΈΠ³ΡΠ½Π°Π»ΡΠ½ΠΈΠΉ ΠΏΡΠ΄Ρ
ΡΠ΄ ΠΊ Π²ΠΈΠΊΠΎΡΠΈΡΡΠ°Π½Π½Ρ ΠΏΠ»Π°Π·ΠΌΠΎΠ²ΠΎΠ³ΠΎ ΠΏΡΠΈΡΠΊΠΎΡΡΠ²Π°ΡΠ° Π· Π²ΡΠ΄ΠΊΡΠΈΡΠΈΠΌΠΈ ΡΡΡΠ½ΠΊΠ°ΠΌΠΈ ΡΠ°
Π·Π°ΠΌΠΊΠ½ΡΡΠΈΠΌ Π΄ΡΠ΅ΠΉΡΠΎΠΌ Π΅Π»Π΅ΠΊΡΡΠΎΠ½ΡΠ² Π΄Π»Ρ ΡΡΠ²ΠΎΡΠ΅Π½Π½Ρ Π΅ΡΠ΅ΠΊΡΠΈΠ²Π½ΠΈΡ
ΠΏΡΠΈΡΡΡΠΎΡΠ² Π·Π°Π΄Π»Ρ Π·Π°ΡΡΠΎΡΡΠ²Π°Π½Π½Ρ Π² ΡΡΡΠ°ΡΠ½ΠΈΡ
ΡΠ΅Ρ
Π½ΠΎΠ»ΠΎΠ³ΡΡΡ
, ΡΠ°ΠΊΠΈΡ
ΡΠΊ ΠΌΠΎΠ΄ΠΈΡΡΠΊΠ°ΡΡΡ ΠΏΠΎΠ²Π΅ΡΡ
ΠΎΠ½Ρ, ΠΊΠ΅ΡΡΠ²Π°Π½Π½Ρ ΠΏΡΡΠΊΠ°ΠΌΠΈ Π·Π°ΡΡΠ΄ΠΆΠ΅Π½ΠΈΡ
ΡΠ°ΡΡΠΈΠ½ΠΎΠΊ ΡΠ° ΡΠΊ ΠΏΡΠΎΡΠΎΡΠΈΠΏ
ΠΌΠ°Π½Π΅Π²ΡΠΎΠ²ΠΈΡ
ΠΊΠΎΡΠΌΡΡΠ½ΠΈΡ
ΡΠΎΠ½Π½ΠΈΡ
Π΄Π²ΠΈΠ³ΡΠ½ΡΠ². ΠΠ°Π²Π΅Π΄Π΅Π½ΠΎ ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΠΈ Π΅ΠΊΡΠΏΠ΅ΡΠΈΠΌΠ΅Π½ΡΠ°Π»ΡΠ½ΠΈΡ
Π΄ΠΎΡΠ»ΡΠ΄ΠΆΠ΅Π½Ρ. ΠΠΎΠ±ΡΠ΄ΠΎΠ²Π°Π½ΠΎ
Π΄Π²ΠΎΠ²ΠΈΠΌΡΡΠ½Ρ Π³ΡΠ±ΡΠΈΠ΄Π½Ρ ΠΌΠΎΠ΄Π΅Π»Ρ Ρ ΠΏΡΠ΅Π΄ΡΡΠ°Π²Π»Π΅Π½ΠΎ ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΠΈ ΡΠΈΡΠ΅Π»ΡΠ½ΠΎΠ³ΠΎ ΠΌΠΎΠ΄Π΅Π»ΡΠ²Π°Π½Π½Ρ.OΠΏΠΈΡΠ°Π½ ΠΎΡΠΈΠ³ΠΈΠ½Π°Π»ΡΠ½ΡΠΉ ΠΏΠΎΠ΄Ρ
ΠΎΠ΄ ΠΊ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΡ ΠΏΠ»Π°Π·ΠΌΠ΅Π½Π½ΠΎΠ³ΠΎ ΡΡΠΊΠΎΡΠΈΡΠ΅Π»Ρ Ρ ΠΎΡΠΊΡΡΡΡΠΌΠΈ ΡΡΠ΅Π½ΠΊΠ°ΠΌΠΈ ΠΈ
Π·Π°ΠΌΠΊΠ½ΡΡΡΠΌ Π΄ΡΠ΅ΠΉΡΠΎΠΌ ΡΠ»Π΅ΠΊΡΡΠΎΠ½ΠΎΠ² Π΄Π»Ρ ΡΠΎΠ·Π΄Π°Π½ΠΈΡ ΡΡΡΠ΅ΠΊΡΠΈΠ²Π½ΠΎΠ³ΠΎ ΡΡΡΡΠΎΠΉΡΡΠ²Π°, ΠΊΠΎΡΠΎΡΠΎΠ΅ ΠΌΠΎΠΆΠ΅Ρ Π±ΡΡΡ
ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΎ Π² ΡΠΎΠ²ΡΠ΅ΠΌΠ΅Π½Π½ΡΡ
ΡΠ΅Ρ
Π½ΠΎΠ»ΠΎΠ³ΠΈΡΡ
, Π² ΡΠ°ΡΡΠ½ΠΎΡΡΠΈ Π΄Π»Ρ ΠΌΠΎΠ΄ΠΈΡΠΈΠΊΠ°ΡΠΈΠΈ ΠΏΠΎΠ²Π΅ΡΡ
Π½ΠΎΡΡΠ΅ΠΉ, ΡΠΏΡΠ°Π²Π»Π΅Π½ΠΈΡ
ΠΏΡΡΠΊΠ°ΠΌΠΈ Π·Π°ΡΡΠΆΠ΅Π½Π½ΡΡ
ΡΠ°ΡΡΠΈΡ, Π° ΡΠ°ΠΊΠΆΠ΅ ΠΊΠ°ΠΊ ΠΏΡΠΎΡΠΎΡΠΈΠΏ ΠΌΠ°Π»ΠΎΠ³Π°Π±Π°ΡΠΈΡΠ½ΠΎΠ³ΠΎ ΡΠ°ΠΊΠ΅ΡΠ½ΠΎΠ³ΠΎ Π΄Π²ΠΈΠ³Π°ΡΠ΅Π»Ρ. ΠΡΠΈΠ²Π΅Π΄Π΅Π½Ρ
ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΡ ΡΠΊΡΠΏΠ΅ΡΠΈΠΌΠ΅Π½ΡΠ°Π»ΡΠ½ΡΡ
ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠΉ. ΠΠΎΡΡΡΠΎΠ΅Π½Π° Π΄Π²ΡΠΌΠ΅ΡΠ½Π°Ρ Π³ΠΈΠ±ΡΠΈΠ΄Π½Π°Ρ ΠΌΠΎΠ΄Π΅Π»Ρ ΠΈ ΠΏΡΠ΅Π΄ΡΡΠ°Π²Π»Π΅Π½Ρ
ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΡ ΡΠΈΡΠ»Π΅Π½Π½ΠΎΠ³ΠΎ ΠΌΠΎΠ΄Π΅Π»ΠΈΡΠΎΠ²Π°Π½ΠΈΡ
Final-state interactions in the response of nuclear matter
Final-state interactions in the response of a many-body system to an external
probe delivering large momentum are normally described using the eikonal
approximation, for the trajectory of the struck particle, and the frozen
approximation, for the positions of the spectators. We propose a generalization
of this scheme, in which the initial momentum of the struck particle is
explicitly taken into account. Numerical calculations of the nuclear matter
response at 1 2 GeV/c show that the inclusion of this momentum
dependence leads to a sizable effect in the low energy tail. Possible
implications for the analysis of existing electron-nucleus scattering data are
discussed.Comment: 21 pages, 4 figure
Sensitivity of Cross Sections for Elastic Nucleus-Nucleus Scattering to Halo Nucleus Density Distributions
In order to clear up the sensitivity of the nucleus-nucleus scattering to the
nuclear matter distributions of exotic halo nuclei, we have calculated
differential cross sections for elastic scattering of the He and Li
nuclei on several nuclear targets at the energy of 0.8 GeV/nucleon with
different assumed nuclear density distributions in He and Li.Comment: 10 pages, 7 figures. Submitted to Proceedings of the 61 International
Conference "Nucleus-2011" on the Problems of the Nuclear Spectroscopy and the
Atomic Nuclear Structure, Sarov Nijzegorodskaya district, October 10-14, 201
Effect of lithium borate coating on the electrochemical properties of LiCoO2 electrode for lithium-ion batteries
The effect of a protective coating of fused lithium borate, Li3BO3, on the physicochemical and electrochemical characteristics of LiCoO2 has been studied. A cathode material produced by the SCS method using binary organic fuel, glycine and citric acid. The influence of the experiment conditions on the morphology, crystal structure and specific surface of lithium cobaltite was studied. Electrochemical testing of LiCoO2βnLi3BO3 samples, nΒ =Β 5 and 7 mass %, has been performed in the cathode Li|Li+-electrolyte|LiCoO2βnLi3BO3 half-cell using 1M LiPF6 in EC/DMC mixture (1:1) as electrolyte in the 2.7-4.3 V range at normalized discharge current Π‘/10, Π‘/5, Π‘/2. The maximal initial discharge capacity of 185 mAh/g was detected for the samples with 5 mass % Li3BO3. The coulomb efficiency of optimal materials in the 40th cycle was 99.1%
Π₯ΡΠΎΠΌΠΎΠ³Π΅Π½Π½ΡΠΉ Π°Π½ΡΠΈΠ₯Π°-ΡΠ΅ΡΡ: ΡΠΎΠΎΡΠ½ΠΎΡΠ΅Π½ΠΈΠ΅ ΠΌΠ΅ΠΆΠ΄Ρ Π΅Π΄ΠΈΠ½ΠΈΡΠ°ΠΌΠΈ Π°ΠΊΡΠΈΠ²Π½ΠΎΡΡΠΈ Π³Π΅ΠΏΠ°ΡΠΈΠ½Π° ΠΈ ΠΊΠΎΠ½ΡΠ΅Π½ΡΡΠ°ΡΠΈΠ΅ΠΉ Π°ΠΏΠΈΠΊΡΠ°Π±Π°Π½Π° ΠΈ ΡΠΈΠ²Π°ΡΠΎΠΊΡΠ°Π±Π°Π½Π°
Introduction. The direct oral anticoagulants (DOC) therapy does not require alaboratory control; however, it may be required to determine the anticoagulationlevel to choose a treatment strategy if alarge bleeding is developing or emergency surgery is needed.The objective of this experimental study was to investigate the relationship between the residual factor Xa (FXa) activity, anti-Xa activity units oflow molecular weight heparins (LMWH), and the apixaban and rivaroxaban plasma concentrations in a chromogenic anti-Xa assay.Material and methods. Concentrated DOC solutions were prepared by extracting apixaban and rivaroxaban from crushed tablets using methanol and dimethyl sulfoxide, respectively. The resulting solutions were added to the donor plasma pool until final inhibitor concentrations are achieved in the range from 10 to 100 ng/ml plasma. Anti-Xa activity was determined using an STA-compact analyser and the Liquid anti-Xa reagent kit, an analysis protocol, and calibrators designed to control the LMWH therapy. The effect on the thrombin formation dynamics was investigated using the thrombin generation test (TGT) and the PPR reagent as a trigger (final concentrations of tissue factor are 5 pM, and those of phospholipids are 4 ΞΌM). TGT curves were analysed using the Thrombinoscope program.Results. It was shown that in the anti-Xa activity test version designed to control the LMWH therapy, there is a high correlation (R2 > 0.98) between thelogarithm of the residual factor Xa activity and the content of apixaban and rivaroxaban in the range from 10 to 80 ng/ml. Rivaroxaban shows about 1.5 times more anti-Xa activity than apixaban at equal concentrations. It was also shown that apixaban and rivaroxaban at doses equal both in concentration and in anti-Xa activity differ in their effect on the thrombin formation dynamics and thrombin inactivation in the TGT.Conclusion. In the LMWH anti-Xa activity test version, the measured range of apixaban and rivaroxaban includes 30 ng/ml and 50 ng/ ml concentrations taken as βcut-off pointsβ to determine the treatment tactics in emergency cases. However, thelack of certified DOC calibratorslimits the use of this test in clinical practice.ΠΠ²Π΅Π΄Π΅Π½ΠΈΠ΅. Π’Π΅ΡΠ°ΠΏΠΈΡ ΠΏΡΡΠΌΡΠΌΠΈ ΠΎΡΠ°Π»ΡΠ½ΡΠΌΠΈ Π°Π½ΡΠΈΠΊΠΎΠ°Π³ΡΠ»ΡΠ½ΡΠ°ΠΌΠΈ (ΠΠΠΠ) Π½Π΅ ΡΡΠ΅Π±ΡΠ΅Ρ Π»Π°Π±ΠΎΡΠ°ΡΠΎΡΠ½ΠΎΠ³ΠΎ ΠΊΠΎΠ½ΡΡΠΎΠ»Ρ, ΠΎΠ΄Π½Π°ΠΊΠΎ Π½Π΅ΠΎΠ±Ρ
ΠΎΠ΄ΠΈΠΌΠΎΡΡΡ ΠΎΠΏΡΠ΅Π΄Π΅Π»Π΅Π½ΠΈΡ ΡΡΠΎΠ²Π½Ρ Π°Π½ΡΠΈΠΊΠΎΠ°Π³ΡΠ»ΡΡΠΈΠΈ ΠΌΠΎΠΆΠ΅Ρ ΠΏΠΎΡΡΠ΅Π±ΠΎΠ²Π°ΡΡΡΡ Π΄Π»Ρ Π²ΡΠ±ΠΎΡΠ° ΡΠ°ΠΊΡΠΈΠΊΠΈ Π»Π΅ΡΠ΅Π½ΠΈΡ ΠΏΡΠΈ ΡΠ°Π·Π²ΠΈΡΠΈΠΈ Π±ΠΎΠ»ΡΡΠΎΠ³ΠΎ ΠΊΡΠΎΠ²ΠΎΡΠ΅ΡΠ΅Π½ΠΈΡ ΠΈΠ»ΠΈ Π½Π΅ΠΎΠ±Ρ
ΠΎΠ΄ΠΈΠΌΠΎΡΡΠΈ Π²ΡΠΏΠΎΠ»Π½Π΅Π½ΠΈΡ ΡΡΠΎΡΠ½ΠΎΠΉ ΠΎΠΏΠ΅ΡΠ°ΡΠΈΠΈ.Π¦Π΅Π»ΡΡ ΡΡΠΎΠ³ΠΎ ΡΠΊΡΠΏΠ΅ΡΠΈΠΌΠ΅Π½ΡΠ°Π»ΡΠ½ΠΎΠ³ΠΎ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ ΡΠ²Π»ΡΠ»ΠΎΡΡ ΠΈΠ·ΡΡΠ΅Π½ΠΈΠ΅ Π²Π·Π°ΠΈΠΌΠΎΡΠ²ΡΠ·ΠΈ ΠΌΠ΅ΠΆΠ΄Ρ ΠΎΡΡΠ°ΡΠΎΡΠ½ΠΎΠΉ Π°ΠΊΡΠΈΠ²Π½ΠΎΡΡΡΡ ΡΠ°ΠΊΡΠΎΡΠ° Π₯Π° (Π€Π₯Π°), Π΅Π΄ΠΈΠ½ΠΈΡΠ°ΠΌΠΈ Π°Π½ΡΠΈΠ₯Π°-Π°ΠΊΡΠΈΠ²Π½ΠΎΡΡΠΈ Π³Π΅ΠΏΠ°ΡΠΈΠ½ΠΎΠ² Π½ΠΈΠ·ΠΊΠΎΠΉ ΠΌΠΎΠ»Π΅ΠΊΡΠ»ΡΡΠ½ΠΎΠΉ ΠΌΠ°ΡΡΡ (ΠΠΠΠ) ΠΈ ΠΊΠΎΠ½ΡΠ΅Π½ΡΡΠ°ΡΠΈΠ΅ΠΉ Π² ΠΏΠ»Π°Π·ΠΌΠ΅ Π°ΠΏΠΈΠΊΡΠ°Π±Π°Π½Π° ΠΈ ΡΠΈΠ²Π°ΡΠΎΠΊΡΠ°Π±Π°Π½Π° Π² Ρ
ΡΠΎΠΌΠΎΠ³Π΅Π½Π½ΠΎΠΌ ΡΠ΅ΡΡΠ΅ Π½Π° Π°Π½ΡΠΈΠ₯Π°-Π°ΠΊΡΠΈΠ²Π½ΠΎΡΡΡ ΠΏΠ»Π°Π·ΠΌΡ.ΠΠ°ΡΠ΅ΡΠΈΠ°Π» ΠΈ ΠΌΠ΅ΡΠΎΠ΄Ρ. ΠΠΎΠ½ΡΠ΅Π½ΡΡΠΈΡΠΎΠ²Π°Π½Π½ΡΠ΅ ΡΠ°ΡΡΠ²ΠΎΡΡ ΠΠΠΠ Π±ΡΠ»ΠΈ ΠΏΠΎΠ»ΡΡΠ΅Π½Ρ ΡΠΊΡΡΡΠ°ΠΊΡΠΈΠ΅ΠΉ Π°ΠΏΠΈΠΊΡΠ°Π±Π°Π½Π° ΠΌΠ΅ΡΠ°Π½ΠΎΠ»ΠΎΠΌ, Π° ΡΠΈΠ²Π°ΡΠΎΠΊΡΠ°Π±Π°Π½Π° Π΄ΠΈΠΌΠ΅ΡΠΈΠ»ΡΡΠ»ΡΡΠΎΠΊΡΠΈΠ΄ΠΎΠΌ ΠΈΠ· ΠΈΠ·ΠΌΠ΅Π»ΡΡΠ΅Π½Π½ΡΡ
ΡΠ°Π±Π»Π΅ΡΠΎΠΊ. ΠΠΎΠ»ΡΡΠ΅Π½Π½ΡΠ΅ ΡΠ°ΡΡΠ²ΠΎΡΡ Π΄ΠΎΠ±Π°Π²Π»ΡΠ»ΠΈ ΠΊ ΠΏΡΠ»Ρ ΠΏΠ»Π°Π·ΠΌ Π΄ΠΎΠ½ΠΎΡΠΎΠ² Π΄ΠΎ ΠΊΠΎΠ½Π΅ΡΠ½ΡΡ
ΠΊΠΎΠ½ΡΠ΅Π½ΡΡΠ°ΡΠΈΠΉ ΠΈΠ½Π³ΠΈΠ±ΠΈΡΠΎΡΠΎΠ² Π² Π΄ΠΈΠ°ΠΏΠ°Π·ΠΎΠ½Π΅ ΠΎΡ 10 Π΄ΠΎ 100 Π½Π³/ΠΌΠ» ΠΏΠ»Π°Π·ΠΌΡ. ΠΠΏΡΠ΅Π΄Π΅Π»Π΅Π½ΠΈΠ΅ Π°Π½ΡΠΈΠ₯Π°-Π°ΠΊΡΠΈΠ²Π½ΠΎΡΡΠΈ Π²ΡΠΏΠΎΠ»Π½ΡΠ»ΠΎΡΡ Π½Π° Π°Π½Π°Π»ΠΈΠ·Π°ΡΠΎΡΠ΅ STA-compact Ρ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΠ΅ΠΌ Π½Π°Π±ΠΎΡΠ° ΡΠ΅Π°ΠΊΡΠΈΠ²ΠΎΠ² Liquid anti-Xa, ΠΏΡΠΎΡΠΎΠΊΠΎΠ»Π° Π°Π½Π°Π»ΠΈΠ·Π° ΠΈ ΠΊΠ°Π»ΠΈΠ±ΡΠ°ΡΠΎΡΠΎΠ², ΠΏΡΠ΅Π΄Π½Π°Π·Π½Π°ΡΠ΅Π½Π½ΡΡ
Π΄Π»Ρ ΠΊΠΎΠ½ΡΡΠΎΠ»Ρ ΡΠ΅ΡΠ°ΠΏΠΈΠΈ ΠΠΠΠ. ΠΠ»ΠΈΡΠ½ΠΈΠ΅ Π½Π° Π΄ΠΈΠ½Π°ΠΌΠΈΠΊΡ ΠΎΠ±ΡΠ°Π·ΠΎΠ²Π°Π½ΠΈΡ ΡΡΠΎΠΌΠ±ΠΈΠ½Π° ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π»ΠΈ Ρ ΠΏΠΎΠΌΠΎΡΡΡ ΡΠ΅ΡΡΠ° Π³Π΅Π½Π΅ΡΠ°ΡΠΈΠΈ ΡΡΠΎΠΌΠ±ΠΈΠ½Π° (Π’ΠΠ’) Ρ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΠ΅ΠΌ Π² ΠΊΠ°ΡΠ΅ΡΡΠ²Π΅ ΡΡΠΈΠ³Π³Π΅ΡΠ° PPR-reagent (ΠΊΠΎΠ½Π΅ΡΠ½ΡΠ΅ ΠΊΠΎΠ½ΡΠ΅Π½ΡΡΠ°ΡΠΈΠΈ ΡΠΊΠ°Π½Π΅Π²ΠΎΠ³ΠΎ ΡΠ°ΠΊΡΠΎΡΠ° - 5 ΠΏΠ, Π° ΡΠΎΡΡΠΎΠ»ΠΈΠΏΠΈΠ΄ΠΎΠ² - 4 ΠΌΠΊΠ). ΠΡΠΈΠ²ΡΠ΅ Π’ΠΠ’ Π°Π½Π°Π»ΠΈΠ·ΠΈΡΠΎΠ²Π°Π»ΠΈ Ρ ΠΏΠΎΠΌΠΎΡΡΡ ΠΏΡΠΎΠ³ΡΠ°ΠΌΠΌΡ Thrombinoscope.Π Π΅Π·ΡΠ»ΡΡΠ°ΡΡ. ΠΠΎΠΊΠ°Π·Π°Π½ΠΎ, ΡΡΠΎ Π² Π²Π°ΡΠΈΠ°Π½ΡΠ΅ ΡΠ΅ΡΡΠ° Π½Π° Π°Π½ΡΠΈΠ₯Π°-Π°ΠΊΡΠΈΠ²Π½ΠΎΡΡΡ, ΠΏΡΠ΅Π΄Π½Π°Π·Π½Π°ΡΠ΅Π½Π½ΠΎΠΌ Π΄Π»Ρ ΠΊΠΎΠ½ΡΡΠΎΠ»Ρ ΡΠ΅ΡΠ°ΠΏΠΈΠΈ ΠΠΠΠ, Π½Π°Π±Π»ΡΠ΄Π°Π΅ΡΡΡ Π²ΡΡΠΎΠΊΠ°Ρ ΠΊΠΎΡΡΠ΅Π»ΡΡΠΈΡ (R2 > 0,98) ΠΌΠ΅ΠΆΠ΄Ρ Π»ΠΎΠ³Π°ΡΠΈΡΠΌΠΎΠΌ ΠΎΡΡΠ°ΡΠΎΡΠ½ΠΎΠΉ Π°ΠΊΡΠΈΠ²Π½ΠΎΡΡΠΈ ΡΠ°ΠΊΡΠΎΡΠ° Π₯Π° ΠΈ ΡΠΎΠ΄Π΅ΡΠΆΠ°Π½ΠΈΠ΅ΠΌ Π°ΠΏΠΈΠΊΡΠ°Π±Π°Π½Π° ΠΈ ΡΠΈΠ²Π°ΡΠΎΠΊΡΠ°Π±Π°Π½Π° Π² Π΄ΠΈΠ°ΠΏΠ°Π·ΠΎΠ½Π΅ ΠΎΡ 10 Π΄ΠΎ 80 Π½Π³/ΠΌΠ». Π ΡΠ°Π²Π½ΡΡ
ΠΊΠΎΠ½ΡΠ΅Π½ΡΡΠ°ΡΠΈΡΡ
ΡΠΈΠ²Π°ΡΠΎΠΊΡΠ°Π±Π°Π½ ΠΏΡΠΎΡΠ²Π»ΡΠ΅Ρ ΠΏΡΠΈΠΌΠ΅ΡΠ½ΠΎ Π² 1,5 ΡΠ°Π·Π° Π±ΠΎΠ»ΡΡΡΡ Π°Π½ΡΠΈΠ₯Π°-Π°ΠΊΡΠΈΠ²Π½ΠΎΡΡΡ, ΡΠ΅ΠΌ Π°ΠΏΠΈΠΊΡΠ°Π±Π°Π½. ΠΠΎΠΊΠ°Π·Π°Π½ΠΎ ΡΠ°ΠΊΠΆΠ΅, ΡΡΠΎ Π°ΠΏΠΈΠΊΡΠ°Π±Π°Π½ ΠΈ ΡΠΈΠ²Π°ΡΠΎΠΊΡΠ°Π±Π°Π½ Π² Π΄ΠΎΠ·Π°Ρ
, ΡΠ°Π²Π½ΡΡ
ΠΊΠ°ΠΊ ΠΏΠΎ ΠΊΠΎΠ½ΡΠ΅Π½ΡΡΠ°ΡΠΈΠΈ, ΡΠ°ΠΊ ΠΈ ΠΏΠΎ Π°Π½ΡΠΈΠ₯Π°-Π°ΠΊΡΠΈΠ²Π½ΠΎΡΡΠΈ ΡΠ°Π·Π»ΠΈΡΠ°ΡΡΡΡ ΠΏΠΎ Π²Π»ΠΈΡΠ½ΠΈΡ Π½Π° Π΄ΠΈΠ½Π°ΠΌΠΈΠΊΡ ΠΎΠ±ΡΠ°Π·ΠΎΠ²Π°Π½ΠΈΡ ΠΈ ΠΈΠ½Π°ΠΊΡΠΈΠ²Π°ΡΠΈΠΈ ΡΡΠΎΠΌΠ±ΠΈΠ½Π° Π² Π’ΠΠ’.ΠΠ°ΠΊΠ»ΡΡΠ΅Π½ΠΈΠ΅. Π Π²Π°ΡΠΈΠ°Π½ΡΠ΅ ΡΠ΅ΡΡΠ° Π½Π° Π°Π½ΡΠΈΠ₯Π°-Π°ΠΊΡΠΈΠ²Π½ΠΎΡΡΡ ΠΠΠΠ ΠΈΠ·ΠΌΠ΅ΡΡΠ΅ΠΌΡΠΉ Π΄ΠΈΠ°ΠΏΠ°Π·ΠΎΠ½ Π°ΠΏΠΈΠΊΡΠ°Π±Π°Π½Π° ΠΈ ΡΠΈΠ²Π°ΡΠΎΠΊΡΠ°Π±Π°Π½Π° Π²ΠΊΠ»ΡΡΠ°Π΅Ρ ΠΊΠΎΠ½ΡΠ΅Π½ΡΡΠ°ΡΠΈΠΈ 30 Π½Π³/ΠΌΠ» ΠΈ 50 Π½Π³/ΠΌΠ», ΠΏΡΠΈΠ½ΡΡΡΠ΅ Π² ΠΊΠ°ΡΠ΅ΡΡΠ²Π΅ Β«ΠΎΡΡΠ΅Π·Π½ΡΡ
ΡΠΎΡΠ΅ΠΊΒ» Π΄Π»Ρ ΠΎΠΏΡΠ΅Π΄Π΅Π»Π΅Π½ΠΈΡ ΡΠ°ΠΊΡΠΈΠΊΠΈ Π»Π΅ΡΠ΅Π½ΠΈΡ Π² ΡΠΊΡΡΡΠ΅Π½Π½ΡΡ
ΡΠ»ΡΡΠ°ΡΡ
. ΠΠ΄Π½Π°ΠΊΠΎ ΠΎΡΡΡΡΡΡΠ²ΠΈΠ΅ ΡΠ΅ΡΡΠΈΡΠΈΡΠΈΡΠΎΠ²Π°Π½Π½ΡΡ
ΠΊΠ°Π»ΠΈΠ±ΡΠ°ΡΠΎΡΠΎΠ² ΠΠΠΠ ΠΎΠ³ΡΠ°Π½ΠΈΡΠΈΠ²Π°Π΅Ρ Π²ΠΎΠ·ΠΌΠΎΠΆΠ½ΠΎΡΡΡ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΡ ΡΡΠΎΠ³ΠΎ ΡΠ΅ΡΡΠ° Π² ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΏΡΠ°ΠΊΡΠΈΠΊΠ΅
- β¦